Organic Letters
Letter
however, of literature precedence involving trans-styryl acetic
acids undergoing Heck-type reactions.
(15) Wang, D.-H.; Mei, T.-S.; Yu, J.-Q. J. Am. Chem. Soc. 2008, 130,
7676−17677.
1
(
16) Cheng, X.-F.; Li, Y.; Su, Y.-M.; Yin, F.; Wang, J.-Y.; Sheng, J.; Vora,
It is noteworthy that the structure of 4ap is related to
Amitriptyline, a medication that has been used in the treatment
H. U.; Wang, X.-S.; Yu, J.-Q. J. Am. Chem. Soc. 2013, 135, 1236−1239.
(17) Goossen, L. J.; Rodríguez, N.; Goossen, K. Angew. Chem., Int. Ed.
3
3,34
35
of migraines,
diabetic neuropathy, postherpetic neural-
2
(
(
008, 47, 3100−3120.
18) Rodríguez, N.; Goossen, L. J. Chem. Soc. Rev. 2011, 40, 5030.
19) Fromm, A.; van Wullen, C.; Hackenberger, D.; Goossen, L. J. J.
3
6
35,37
gia, and chronic lower back pain.
In addition, Brown and
co-workers reported an analog of Amitriptyline, diphenylamine
DHP-362, which exhibits higher potency as a sodium channel
̈
Am. Chem. Soc. 2014, 136, 10007−10023.
3
8
blocker. The synthesis of DHP-362 is only two steps away from
ap. We next examined the arylation of trans-styryl acetic acid 4a
(20) Weaver, J. D.; Recio, A., III; Grenning, A. J.; Tunge, J. A. Chem.
Rev. 2011, 111, 1846−1913.
4
with different aryl bromides. Both 4-tert-Bu and 4-F groups
underwent reaction with excellent regioselectivity and afforded
E/Z-mixtures in 71−78% yields.
(21) Chen, F.; Wang, T.; Jiao, N. Chem. Rev. 2014, 114, 8613−8661.
(
22) Shang, R.; Yang, Z.-W.; Wang, Y.; Zhang, S.-L.; Liu, L. J. Am.
39
Chem. Soc. 2010, 132, 14391−14393.
23) Shang, R.; Huang, Z.; Chu, L.; Fu, Y.; Liu, L. Org. Lett. 2011, 13,
240−4243.
24) Zheng, B.; Jia, T.; Walsh, P. J. Adv. Synth. Catal. 2014, 356, 165−
78.
25) Jia, T.; Bellomo, A.; Montel, S.; Zhang, M.; El Baina, K.; Zheng, B.;
(
4
(
1
In summary, we have developed a general method for
palladium-catalyzed α-arylation of aryl acetic acids with aryl
bromides and chlorides. The reaction also affords product with
trans-styryl acetic acid, which provides intermediates in route to
biologically active compounds. We anticipate that this protocol
will be an important complement to the existing arsenal of
palladium-catalyzed α-arylation reactions.
(
Walsh, P. J. Angew. Chem., Int. Ed. 2013, 53, 260−264.
(26) Montel, S.; Jia, T.; Walsh, P. J. Org. Lett. 2014, 16, 130−133.
(27) Montel, S.; Raffier, L.; He, Y.; Walsh, P. J. Org. Lett. 2014, 16,
1
446−1449.
ASSOCIATED CONTENT
Supporting Information
(28) Zhang, J.; Bellomo, A.; Creamer, A. D.; Dreher, S. D.; Walsh, P. J.
■
J. Am. Chem. Soc. 2012, 134, 13765−13772.
*
S
(
(
29) Zheng, B.; Jia, T.; Walsh, P. J. Org. Lett. 2013, 15, 1690−1693.
30) Jia, T.; Bellomo, A.; Baina, K. E.; Dreher, S. D.; Walsh, P. J. J. Am.
Chem. Soc. 2013, 135, 3740−3743.
(31) Zheng, B.; Jia, T.; Walsh, P. J. Org. Lett. 2013, 15, 4190−4193.
(32) Bordwell, F. G.; Matthews, W. S.; Vanier, N. R. J. Am. Chem. Soc.
AUTHOR INFORMATION
1975, 97, 442−443.
33) Cerbo, R.; Barbanti, P.; Fabbrini, G.; Pascali, M. P.; Catarci, T.
Headache 1998, 38, 453−457.
■
*
(
Notes
(
34) Ashina, S.; Bendtsen, L.; Jensen, R. Pain 2004, 108, 108−114.
(35) Collins, S. L.; Moore, R. A.; McQuay, H. J.; Wiffen, P. J. Pain
Symptom. Manage. 2000, 20, 449−458.
The authors declare no competing financial interest.
(36) Bowsher, D. Eur. J. Pain 2003, 7, 1−7.
(37) Atkinson, J. H.; Slater, M. A.; Williams, R. A.; Zisook, S.;
ACKNOWLEDGMENTS
■
Patterson, T. L.; Grant, I.; Wahlgren, D. R.; Abramson, I.; Garfin, S. R.
We thank the National Science Foundation (CHE-1152488) and
National Institutes of Health (NIGMS 104349) for financial
support.
Pain 1998, 76, 287−296.
(38) Hudgens, D. P.; Taylor, C.; Batts, T. W.; Patel, M. K.; Brown, M.
L. Bioorg. Med. Chem. 2006, 14, 8366−8378.
(39) Harbert, C. A.; Koe, B. K.; Kraska, A. R.; Welch, W. M., Jr.,
Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naph-
thalenamine, U.S. Patent 4,536,518, August 20, 1985.
REFERENCES
■
(
(
1) Culkin, D. A.; Hartwig, J. F. Acc. Chem. Res. 2003, 36, 234−245.
2) Satoh, T.; Kawamura, Y.; Miura, M.; Nomura, M. Angew. Chem., Int.
Ed. Engl. 1997, 36, 1740−1742.
3) Palucki, M.; Buchwald, S. L. J. Am. Chem. Soc. 1997, 119, 11108−
1109.
4) Hamann, B. C.; Hartwig, J. F. J. Am. Chem. Soc. 1997, 119, 12382−
2383.
5) Johansson, C. C. C.; Colacot, T. J. Angew. Chem., Int. Ed. 2010, 49,
(
1
(
1
(
6
(
(
76−707.
6) Bellina, F.; Rossi, R. Chem. Rev. 2009, 110, 1082−1146.
7) Chiong, H. A.; Pham, Q.-N.; Daugulis, O. J. Am. Chem. Soc. 2007,
1
29, 9879−9884.
8) Wu, G.-J.; Guan, J.; Han, F.-S.; Zhao, Y.-L. ChemCatChem 2014, 6,
589−1593.
9) Tanaka, D.; Tanaka, S.; Mori, A. Eur. J. Org. Chem. 2014, 20, 4254−
257.
10) Nwokogu, G. C.; Wong, J.-W.; Greenwood, T. D.; Wolfe, J. F. Org.
Lett. 2000, 2, 2643−2646.
11) Hauser, C. R.; Chambers, W. J. J. Am. Chem. Soc. 1956, 78, 4942−
944.
(
1
(
4
(
(
4
(
(
12) Creger, P. L. J. Am. Chem. Soc. 1967, 89, 2500−2501.
13) Pfeffer, P. E.; Silbert, L. S.; Chirinko, J. M., Jr. J. Org. Chem. 1972,
3
(
7
7, 451−458.
14) Streitwieser, A.; Husemann, M.; Kim, Y.-J. J. Org. Chem. 2003, 68,
937−7942.
D
Org. Lett. XXXX, XXX, XXX−XXX